Northwestern Mutual Wealth Management
IMMX icon

Northwestern Mutual Wealth Management’s Immix Biopharma IMMX Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio IMMX Stock Details IMMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$113 Buy
+11
New +$102 ﹤0.01% 3982
2026
Q1 		– Sell
-3
Closed -$16 – 4306
2025
Q4 		$16 Sell
3
-77
-96% -$317 ﹤0.01% 3958
2025
Q3 		$167 Hold
80
– – ﹤0.01% 3700
2025
Q2 		$166 Hold
80
– – ﹤0.01% 3525
2025
Q1 		$134 Buy
+80
New +$151 ﹤0.01% 3487

Other funds holding IMMX

JT
Jupiter Topco New York $245B AUM
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Northwestern Mutual Wealth Management's IMMX Position: Q2 2026 in Review

Northwestern Mutual Wealth Management opened a new position in Immix Biopharma (IMMX) in Q2 2026: 11 shares worth $113. The stake represents ﹤0.01% of the portfolio and ranks #3982 among its holdings. This is a return to the name: Northwestern Mutual Wealth Management previously reported a position in IMMX as recently as Q4 2025.

Northwestern Mutual Wealth Management first reported a position in IMMX in Q1 2025 and has held it in 5 quarters since. The position peaked at $167 in Q3 2025. 109 funds tracked by Wall St. Rank hold IMMX as of Q2 2026.

  • Northwestern Mutual Wealth Management held 11 shares of Immix Biopharma worth $113 as of Q2 2026.
  • Immix Biopharma was a new Northwestern Mutual Wealth Management position in Q2 2026.
  • Immix Biopharma made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #3982 holding.
  • Northwestern Mutual Wealth Management first reported a position in Immix Biopharma in Q1 2025 and has held it in 5 quarters since.
  • Northwestern Mutual Wealth Management's Immix Biopharma position peaked at $167 in Q3 2025.
  • 109 funds tracked by Wall St. Rank held Immix Biopharma as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.